AVITA Medical (AVHHL) Receivables - Other (2020 - 2024)

AVITA Medical has reported Receivables - Other for 5 years, with the latest figure at $111000.0 in Q3 2024.

• For the quarter ending Q3 2024, Receivables - Other changed N/A year-over-year to $111000.0; the trailing twelve-month figure through Sep 2024 stood at $111000.0 (changed N/A YoY), and the FY2022 full-year result was $898000.0, up 191.56% from the prior year.
• Receivables - Other for Q3 2024 stood at $111000.0, up from $28000.0 in the prior quarter.
• The five-year high for Receivables - Other was $3.9 million in Q2 2021, with the low at $28000.0 in Q1 2024.
• Historically, Receivables - Other has averaged $907142.9 across 5 years, with a median of $479000.0 in 2023.
• Annual changes were most pronounced in 2021 — Receivables - Other soared 1005.62% — and 2024, when it plunged 94.57%.
• AVITA Medical's Receivables - Other stood at $440000.0 in 2020, then fell by 30.0% to $308000.0 in 2021, then soared by 191.56% to $898000.0 in 2022, then tumbled by 50.78% to $442000.0 in 2023, then slumped by 74.89% to $111000.0 in 2024.
• The last three Receivables - Other figures came in at $111000.0 (Q3 2024), $28000.0 (Q1 2024), and $442000.0 (Q2 2023), per Business Quant data.